AFM
CLGN icon

Anson Funds Management’s CollPlant Biotechnologies CLGN Stock Holding History

Anson Funds Management’s Portfolio CLGN Stock Details CLGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-159,401
Closed -$217K – 123
2025
Q2 		$217K Buy
+159,401
New +$330K 0.03% 96

Other funds holding CLGN

SDJVC
St. Denis J. Villere & Co New Orleans, Louisiana $907M AUM 10.61% 1-Year Est. Return
PA
Pinnacle Associates New York $7.78B AUM 45.07% 1-Year Est. Return
AE
AMH Equity Great Neck, New York $80.3M AUM 78.34% 1-Year Est. Return
Brown Advisory
Brown Advisory Baltimore, Maryland $60.9B AUM 15.24% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
HCM
Heights Capital Management San Francisco, California $359M AUM 7.93% 1-Year Est. Return
Pathstone Holdings
Pathstone Holdings Englewood, New Jersey $25.1B AUM 22.95% 1-Year Est. Return
WPC
Waters Parkerson & Co New Orleans, Louisiana $1.95B AUM 15.9% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return
FIA
FNY Investment Advisers New York $278M AUM 98.95% 1-Year Est. Return

Anson Funds Management's CLGN Position: Q3 2025 in Review

Anson Funds Management sold out of CollPlant Biotechnologies (CLGN) in Q3 2025, closing a stake of 159,401 shares — an estimated $217K sold.

Anson Funds Management first reported a position in CLGN in Q2 2025 and held it in 1 quarter. The position peaked at $217K in Q2 2025. 19 funds tracked by Wall St. Rank hold CLGN as of Q3 2025.

  • Anson Funds Management reported no remaining CollPlant Biotechnologies position as of Q3 2025 after selling out during the quarter.
  • Anson Funds Management sold 159,401 CollPlant Biotechnologies shares in Q3 2025, an estimated $217K.
  • Anson Funds Management first reported a position in CollPlant Biotechnologies in Q2 2025 and held it in 1 quarter.
  • Anson Funds Management's CollPlant Biotechnologies position peaked at $217K in Q2 2025.
  • 19 funds tracked by Wall St. Rank held CollPlant Biotechnologies as of Q3 2025.

Based on Anson Funds Management's 13F filing for Q3 2025, filed 14 Nov 2025.